Who's Afraid Of A Tweet And A Pin? Strategies To Start Engaging Online
Executive Summary
Lubna Ahmed explores how pharma can benefit from using social media, where the industry is at now and the different ways it could make the most out of the tools that have become centerpieces of our world's communication.
You may also be interested in...
Social Media/Mobile Health Data: What's It Good For?
Whether its tweets on Twitter, posts on Facebook or vital signs being recorded by wearable fitness trackers and cell phone apps, the data from social media and mobile health devices have been coming fast and furious in recent years – and abundantly accumulating.
Boehringer out tweets, pins, posts and shares its peers
The number of followers for pharma companies on Twitter has increased nearly 300% since 2013 – but has pharma got any better at communicating on social media?
Biosimilars, social media among 2015 expected FDA guidances
The FDA on 6 January issued its agenda, without specific dates, for new and revised draft guidances expected to be issued in 2015 by the Center for Drug Evaluation and Research (CDER), including the much anticipated documents affecting biosimilar products and drug makers' use of social media.